On December 16, 2015 NIH released its NIH-Wide Strategic Plan, Fiscal Years 2016-2020: Turning Discovery Into Health. The Endocrine Society provided input to the NIH during the strategic planning process and sent a letter to the Director of NIH, Francis Collins, MD, and NIH Principal Deputy Director, Lawrence Tabak, DDS, PhD. In our comments, the...
NIH Clarifies Instructions to Grantees on Incorporating Sex as a Biological Variable
In 2014, in response to requests by the Endocrine Society, the National Institutes of Health (NIH) announced that it would develop policies to require investigators to account for sex as a fundamental biological variable in NIH-supported preclinical research. The Endocrine Society wholeheartedly supports the goal of ensuring that sex is considered in studies funded by...
Endocrine Society Supports Proper Specialty Care Reimbursement
As the Centers for Medicare and Medicaid Services (CMS) begins the process to transition physician payment from a system that pays by volume to one that pays for value, the Endocrine Society continues to have concern that new payment models properly value cognitive services and not only focus on procedures. As a result, the Endocrine...
The Republican-led Congress and Democratic White House just closed out a surprisingly productive year in 2015, marked by the long-fought repeal of the Medicare physician payment system and passage of a $1.15 trillion spending bill that included a $2-billion increase for the National Institutes of Health (NIH) – two of the Endocrine Society’s top legislative... The Endocrine Society increasingly is called to contribute to policy discussions in the U.S. and globally concerning regulation of endocrine disrupting chemicals (EDCs). The Society’s goal in reaching out to regulators, policymakers, and other stakeholders is to ensure that regulatory decisions involving EDCs incorporate relevant endocrine principles and are informed by modern endocrine science. In...
Congress Reaches Compromise on FY 2016 Funding; Provides $2 Billion for NIH
After much debate and negotiation, Congress reached a compromise on the fiscal year (FY) 2016 appropriations bill that will finalize the budgets for the National Institutes of Health (NIH) and other research agencies through September. The bill includes $32 billion for NIH (a $2 billion increase), the amount recommended by the Endocrine Society. The omnibus...
The Endocrine Society increasingly is called to contribute to policy discussions in the U.S. and globally concerning regulation of endocrine-disrupting chemicals (EDCs). The Society’s goal in reaching out to regulators, policymakers, and other stakeholders is to ensure that regulatory decisions involving EDCs incorporate relevant endocrine principles and are informed by modern endocrine science. In November...
As this item is posted, the fate of the fiscal year (FY) 2016 budget for the National Institutes of Health (NIH) remains uncertain. While Congress was able to reach a budget agreement in September that raises the amount of spending allowed and opens the door for an increase for NIH and other programs, Congress is...
Endocrinology Advocacy
Not all topics of relevance to endocrinologists are about specific conditions and diseases. Sometimes, doctors need information about changes in the medical field or the field of endocrinology. Changes to medical insurance legislation, drug trial regulations and even patient privacy legislation all impact a practitioner’s way of doing business and practicing medicine. Yet keeping track of these details is not always easy. That’s why Endocrine News has organized articles and news pieces on these topics into this advocacy page. Here, practitioners can find the information gathered by the Endocrine Society, a leading endocrinology advocacy organization, conveniently in one location.
Important Advocacy Information From the Endocrine Society
As an endocrinology advocacy organization, the Endocrine Society is constantly working to advocate for endocrinologists and their patients, both in the government and in various research centers across the country. Here on Endocrine News, you can stay informed about these efforts and their results, so you are well aware of what changes may be coming that affect your practice. This is an invaluable resource for doctors who wish to spend their time focusing on their patients, rather than advocating for their practices, but also wish to stay informed about what is happening in the field.
Both Clinical and Research Advocacy Information
On the Advocacy page, Endocrine News provides advocacy information relevant to both those in the research field and those practicing on a clinical level. Stay up to date with the activities of the Endocrine Society, learn more about the legislation that affects your work, and see highlights of leading researchers who are pioneering not only advances in the practice but also advocacy for endocrinology as a field. By utilizing the resources on the Advocacy page, you will be better equipped to meet the needs of your patients while staying abreast on the changes affecting the industry.
